Skip to content

Clinical trials

Phase 4 Metabolic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 4 Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
200411
20058
200615
200712
200812
20097
20107
20116
20125
20136
20144
20154
20163
20184
20194
20204
20213
20223
20234
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Unknown status24
Terminated13
Recruiting9
Not yet recruiting5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis7
Vanderbilt University3
Vanderbilt University Medical Center3
AstraZeneca2
Bristol-Myers Squibb2
Korea University Anam Hospital2
Leiden University Medical Center2
Seoul National University Hospital2
Taichung Veterans General Hospital2
UMC Utrecht2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome139
Obesity27
Insulin Resistance25
Hypertension20
Schizophrenia16
Diabetes Mellitus, Type 213
Diabetes Mellitus10
Cardiovascular Diseases9
Hypogonadism7
Psychotic Disorders7

Trials

Showing 51 to 75 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.